Investing.com – France stocks were higher after the close on Monday, as gains in the Foods & Drugs, Gas & Water and General Financial sectors led shares higher. At the close in...
Investing.com – France stocks were higher after the close on Friday, as gains in the Foods & Drugs, Gas & Water and General Financial sectors led shares higher. At the close in...
Investing.com – France stocks were higher after the close on Thursday, as gains in the Foods & Drugs, Gas & Water and General Financial sectors led shares higher. At the close in...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Buy | Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Buy | Strong Sell | Strong Buy |
| Summary | Strong Buy | Strong Buy | Buy | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,351.93 | 2,371.25 | 2,346.16 | +14.58 | +0.62% | 1.44M | NASDAQ | |||
| 319.08 | 322.94 | 318.75 | -0.94 | -0.29% | 15.92M | NASDAQ | |||
| 225.31 | 228.79 | 225.05 | -1.11 | -0.49% | 10.55M | NYSE | |||
| 2.64 | 2.74 | 2.61 | -0.0200 | -0.75% | 8.70M | NASDAQ | |||
| 191.55 | 198.49 | 189.51 | -0.78 | -0.41% | 7.43M | NASDAQ | |||
| 35.57 | 35.59 | 34.81 | +0.59 | +1.69% | 6.80M | NYSE | |||
| 18.70 | 19.23 | 18.07 | +0.89 | +5.00% | 7.27M | NASDAQ | |||
| 16.18 | 17.02 | 15.04 | +2.03 | +14.35% | 74.84M | NASDAQ | |||
| 14.08 | 14.10 | 13.78 | +0.15 | +1.08% | 12.73M | NASDAQ | |||
| 9.85 | 9.87 | 9.77 | +0.03 | +0.31% | 48.87K | NYSE | |||
| 7.25 | 7.28 | 6.67 | +0.32 | +4.62% | 85.44K | NASDAQ | |||
| 11.50 | 11.94 | 11.40 | 0.00 | 0.00% | 20.59K | NASDAQ | |||
| 19.30 | 20.65 | 18.41 | +1.07 | +5.87% | 2.44M | NASDAQ | |||
| 28.01 | 28.20 | 27.55 | +0.10 | +0.36% | 66.86K | NASDAQ | |||
| 11.86 | 12.30 | 11.61 | +0.2300 | +1.98% | 673.49K | NASDAQ |
Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets.